Geode Capital Management
TSVT

Geode Capital Management’s 2seventy bio TSVT Stock Holding History

Geode Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,207,345
Closed -$5.97M – 4521
2025
Q1 		$5.97M Buy
1,207,345
+33,084
+3% +$105K ﹤0.01% 2578
2024
Q4 		$3.45M Sell
1,174,261
-1,983
-0.2% -$8.13K ﹤0.01% 2923
2024
Q3 		$5.55M Buy
1,176,244
+13,144
+1% +$59.3K ﹤0.01% 2703
2024
Q2 		$4.48M Buy
1,163,100
+20,067
+2% +$90.5K ﹤0.01% 2795
2024
Q1 		$6.12M Buy
1,143,033
+54,166
+5% +$255K ﹤0.01% 2585
2023
Q4 		$4.65M Buy
1,088,867
+43,510
+4% +$134K ﹤0.01% 2738
2023
Q3 		$4.1M Buy
1,045,357
+62,131
+6% +$407K ﹤0.01% 2742
2023
Q2 		$9.95M Buy
983,226
+241,754
+33% +$2.56M ﹤0.01% 2291
2023
Q1 		$7.56M Buy
741,472
+25,843
+4% +$295K ﹤0.01% 2425
2022
Q4 		$6.71M Buy
715,629
+19,324
+3% +$273K ﹤0.01% 2500
2022
Q3 		$10.1M Buy
696,305
+18,114
+3% +$269K ﹤0.01% 2248
2022
Q2 		$8.95M Buy
678,191
+244,835
+56% +$3.34M ﹤0.01% 2338
2022
Q1 		$7.39M Buy
433,356
+36,778
+9% +$624K ﹤0.01% 2558
2021
Q4 		$10.2M Buy
+396,578
New +$12.4M ﹤0.01% 2440

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Geode Capital Management's TSVT Position: Q2 2025 in Review

Geode Capital Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 1,207,345 shares — an estimated $5.97M sold.

Geode Capital Management first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $10.2M in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Geode Capital Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Geode Capital Management sold 1,207,345 2seventy bio shares in Q2 2025, an estimated $5.97M.
  • Geode Capital Management first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Geode Capital Management's 2seventy bio position peaked at $10.2M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.